|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Tracon Pharmaceuticals, Inc. (TCON) |
|
|
$0.26 0.00 (0.00%) as of 4:30 Fri 4/5
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
13,680,000 |
Market
Cap: |
3.49(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0.1322 - $0.64 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile TRACON Pharmaceuticals is a biopharmaceutical company. Co. has a collaboration and clinical trial agreement for the development of envafolimab, an investigational PD-L1 single-domain antibody for the treatment of soft tissue sarcoma in North America. Other clinical stage oncology product candidates include: YH001, which is a monospecific investigational CTLA-4 antibody, that Co. licensed from Eucure (Beijing) Biopharma Co., Ltd. and Biocytogen Pharmaceuticals (Beijing) Co., Ltd., TRC102, which is a small molecule for the treatment of mesothelioma, lung cancer, glioblastoma and solid tumors, and TJ004309, which is a CD73 antibody for the treatment of solid tumors.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
1,418,993 |
Total Buy Value |
$0 |
$0 |
$0 |
$1,892,637 |
Total People Bought |
0 |
0 |
0 |
3 |
Total Buy Transactions |
0 |
0 |
0 |
30 |
Total Shares Sold |
0 |
0 |
4,764,008 |
4,765,667 |
Total Sell Value |
$0 |
$0 |
$1,401,571 |
$1,403,938 |
Total People Sold |
0 |
0 |
1 |
2 |
Total Sell Transactions |
0 |
0 |
1 |
3 |
End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Brown Scott B. |
Chief Financial Officer |
|
2021-03-08 |
4 |
B |
$8.30 |
$8,296 |
D/D |
1,000 |
3,128 |
2.74 |
-36% |
|
Theuer Charles |
President and CEO |
|
2021-01-27 |
4 |
B |
$8.98 |
$98,771 |
D/D |
11,000 |
201,232 |
2.81 |
-22% |
|
Shahrestani Neil |
Member of 10% Group |
|
2020-12-30 |
4 |
B |
$9.61 |
$4,999,997 |
I/I |
520,291 |
2,716,840 |
1.5 |
-45% |
|
Wiggins Mark C |
Chief Business Officer |
|
2020-12-29 |
4 |
B |
$10.56 |
$10,570 |
D/D |
1,000 |
13,700 |
2.74 |
-43% |
|
Theuer Charles |
President and CEO |
|
2020-12-29 |
4 |
B |
$9.98 |
$9,980 |
D/D |
1,000 |
190,232 |
2.81 |
-43% |
|
Opaleye Management Inc. |
10% Owner |
|
2020-12-22 |
4 |
B |
$8.06 |
$3,999,993 |
I/I |
496,277 |
2,293,371 |
1.5 |
-19% |
|
Shahrestani Neil |
Member of 10% Group |
|
2020-11-11 |
4 |
B |
$7.53 |
$37,629 |
I/I |
5,000 |
2,196,549 |
1.5 |
10% |
|
Shahrestani Neil |
Member of 10% Group |
|
2020-10-30 |
4 |
B |
$4.64 |
$98,907 |
I/I |
21,300 |
2,191,549 |
1.5 |
100% |
|
Shahrestani Neil |
Member of 10% Group |
|
2020-10-29 |
4 |
B |
$4.77 |
$36,734 |
I/I |
7,700 |
2,170,249 |
1.5 |
79% |
|
Theuer Charles |
President and CEO |
|
2020-10-21 |
4 |
B |
$4.38 |
$8,769 |
D/D |
2,000 |
189,232 |
2.81 |
91% |
|
Opaleye Management Inc. |
10% Owner |
|
2020-10-21 |
4 |
B |
$4.40 |
$38,060 |
I/I |
8,656 |
1,797,094 |
1.5 |
91% |
|
Opaleye Management Inc. |
10% Owner |
|
2020-09-24 |
4 |
B |
$4.44 |
$95,648 |
I/I |
21,534 |
1,785,438 |
1.5 |
119% |
|
Theuer Charles |
President and CEO |
|
2020-09-23 |
4 |
B |
$4.72 |
$23,599 |
D/D |
5,000 |
186,882 |
2.81 |
116% |
|
Opaleye Management Inc. |
10% Owner |
|
2020-09-23 |
4 |
B |
$4.83 |
$276,448 |
I/I |
57,200 |
1,764,438 |
1.5 |
116% |
|
Shahrestani Neil |
Member of 10% Group |
|
2020-09-11 |
4 |
B |
$3.93 |
$307,017 |
I/I |
78,201 |
2,162,549 |
1.5 |
159% |
|
Wiggins Mark C |
Chief Business Officer |
|
2020-09-10 |
4 |
B |
$4.14 |
$28,953 |
D/D |
7,000 |
12,350 |
2.74 |
151% |
|
Shahrestani Neil |
Member of 10% Group |
|
2020-09-09 |
4 |
B |
$3.49 |
$277,460 |
I/I |
79,415 |
2,084,348 |
1.5 |
184% |
|
Opaleye Management Inc. |
10% Owner |
|
2020-09-09 |
4 |
B |
$3.47 |
$164,773 |
I/I |
47,500 |
1,709,438 |
1.5 |
184% |
|
Shahrestani Neil |
Member of 10% Group |
|
2020-09-08 |
4 |
B |
$2.90 |
$38,408 |
I/I |
13,244 |
2,004,933 |
1.5 |
185% |
|
Shahrestani Neil |
Member of 10% Group |
|
2020-09-04 |
4 |
B |
$2.87 |
$434,502 |
I/I |
151,611 |
1,991,689 |
1.5 |
241% |
|
Opaleye Management Inc. |
10% Owner |
|
2020-09-04 |
4 |
B |
$2.88 |
$26,130 |
I/I |
9,058 |
1,664,438 |
1.5 |
241% |
|
Theuer Charles |
President and CEO |
|
2020-09-04 |
4 |
B |
$2.55 |
$25,750 |
D/D |
10,000 |
181,882 |
2.81 |
241% |
|
Shahrestani Neil |
10% Owner |
|
2020-09-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,840,078 |
|
259% |
|
Ikarian Capital, Llc |
10% Owner |
|
2020-09-03 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,840,078 |
|
259% |
|
Opaleye Management Inc. |
10% Owner |
|
2020-09-02 |
4 |
B |
$2.35 |
$282,057 |
I/I |
119,800 |
1,655,946 |
1.5 |
357% |
|
241 Records found
|
|
Page 4 of 10 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|